| MeSH term | MeSH ID | Detail |
|---|---|---|
| Colitis, Ulcerative | D003093 | 24 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Cholestasis | D002779 | 23 associated lipids |
| Birth Weight | D001724 | 23 associated lipids |
| Shock, Hemorrhagic | D012771 | 4 associated lipids |
| Gastrointestinal Hemorrhage | D006471 | 27 associated lipids |
| Tay-Sachs Disease | D013661 | 2 associated lipids |
| Fetal Resorption | D005327 | 15 associated lipids |
Taurodeoxycholic acid
Taurodeoxycholic acid is a lipid of Sterol Lipids (ST) class. Taurodeoxycholic acid is associated with abnormalities such as Ischemia and Wiskott-Aldrich Syndrome. The involved functions are known as Cell Proliferation, Transcriptional Activation, Phosphorylation, Anabolism and Biochemical Pathway. Taurodeoxycholic acid often locates in Body tissue, Epithelium, Blood, Mucous Membrane and Hepatic. The associated genes with Taurodeoxycholic acid are NOX5 gene, GPBAR1 gene, NR1H4 gene and SLC33A1 gene. The related lipids are cholanic acid, taurolithocholic acid 3-sulfate, Sterols, 7-dehydrocholesterol and tauromuricholic acid.
Cross Reference
Introduction
To understand associated biological information of Taurodeoxycholic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Taurodeoxycholic acid?
Taurodeoxycholic acid is suspected in Ischemia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Taurodeoxycholic acid
PubChem Associated disorders and diseases
What pathways are associated with Taurodeoxycholic acid
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Taurodeoxycholic acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Taurodeoxycholic acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Taurodeoxycholic acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Taurodeoxycholic acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Taurodeoxycholic acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Taurodeoxycholic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Shekels LL et al. | Tauroursodeoxycholic acid protects in vitro models of human colonic cancer cells from cytotoxic effects of hydrophobic bile acids. | 1996 | J. Lab. Clin. Med. | pmid:8592097 |
| Narayanan VS and Storch J | Fatty acid transfer in taurodeoxycholate mixed micelles. | 1996 | Biochemistry | pmid:8652524 |
| Muraca M et al. | Protective effect of tauroursodeoxycholate against acute gastric mucosal injury induced by hydrophobic bile salts. | 1996 | Dig. Dis. Sci. | pmid:8654150 |
| Albalak A et al. | Effects of submicellar bile salt concentrations on biological membrane permeability to low molecular weight non-ionic solutes. | 1996 | Biochemistry | pmid:8672496 |
| Smit JW et al. | Does the HMG-CoA reductase inhibitor pravastatin influence nucleation of cholesterol crystals in supersaturated model bile? | 1996 | Eur J Gastroenterol Hepatol | pmid:8724016 |
| Oude Elferink RP et al. | Uncoupling of biliary phospholipid and cholesterol secretion in mice with reduced expression of mdr2 P-glycoprotein. | 1996 | J. Lipid Res. | pmid:8725158 |
| Heuman DM et al. | Adsorption of mixtures of bile salt taurine conjugates to lecithin-cholesterol membranes: implications for bile salt toxicity and cytoprotection. | 1996 | J. Lipid Res. | pmid:8728319 |
| Trawick JD et al. | Rat hepatoma L35 cells, a liver-differentiated cell line, display resistance to bile acid repression of cholesterol 7 alpha-hydroxylase. | 1996 | J. Lipid Res. | pmid:8728321 |
| DeLong LJ and Nichols JW | Time-resolved fluorescence anisotropy of fluorescent-labeled lysophospholipid and taurodeoxycholate aggregates. | 1996 | Biophys. J. | pmid:8785303 |
| Van Erpecum KJ et al. | Effects of bile salt hydrophobicity on crystallization of cholesterol in model bile. | 1996 | Eur. J. Clin. Invest. | pmid:8864423 |